菜单

Supply Chain Intelligence about:

Sanofi Aventis Recherche & Developpement

企业页面   France

See Sanofi Aventis Recherche & Developpement's products and customers

成千上万家像您这样的公司使用磐聚网搜索供应商和竞争对手。

轻松使用贸易数据

Explore trading relationships hidden in supply chain data

Contact information for Sanofi Aventis Recherche & Developpement

 
地址
RUE DU PROFESSEUR JOSEPH BLAYAC MONTPELLIER CEDEX 04, FRANCIA 34184
 
 

Sample Bill of Lading

130 shipment records available

Bill of Lading Number
4002619
Shipment Date
2014-02-25
Consignee
Sanofi Aventis De Mexico SA De Cv
Consignee (Original Format)
SANOFI AVENTIS DE MEXICO S.A. DE C.V. AV. UNIVERSIDAD, M. A. DE QUEVEDO Y SOSA COYOACAN COYOACAN, DISTRITO FEDERAL, 04000 Mexico
Consignee Tax Number
SAM951123978
Consignee Global HQ
Sanofi
Shipper
Sanofi Aventis Recherche & Developpement
Shipper (Original Format)
SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT RUE DU PROFESSEUR JOSEPH BLAYAC MONTPELLIER CEDEX 04, FRANCIA, 34184 France
Shipper Registration Number
FR67713002269
Shipper Global HQ
Sanofi
Shipper Domestic HQ
Sanofi
Shipment Origin
["United States"]
Port of Unlading
Ciudad de México (MX)
Port of Unlading (Original Format)
AEROPUERTO INTERNACIONAL DE LA CIUDAD DE MEXICO,AEROPUERTO INTERNACIONAL DE LA CIUDAD DE MEXICO
Country of Sale
France
Transport Method
Air
Customs Regime
Final Import / Export
Customs Agent
3312
Gross Weight (kg)
230.0
Gross Weight (t)
0.23
Gross Weight (Original Format)
230.0
Value of Goods, CIF (USD)
$8
Value of Goods, CIF (MXN)
100
Exchange Rate (MXN-USD)
$13
Item Origin
United States
HS Code
98010001
Goods Shipped
XXXXXXXX
Shipment Quantity
750.0
Shipment Unit
Juego
Value of Goods, Item CIF (USD)
$8
Value of Goods, Item CIF (MXN)
100
Shipment Value (MXN)
100
Tax Quantity
14.5
Tax Unit
Kilo
Customs Processing Tax 1 Value (MXN)
259
Value Added Tax 1 Value (MXN)
57
Value Added Tax Rate
16.0
Value Adjusted Code
1
WTO Valuation Method Code
1

Recent Panjiva Research about Sanofi Aventis Recherche & Developpement

20161202-insulin-us

Novo and Lilly Face Tough Growth in Diabetes, Trade Data Shows

The global prevalence of diabetes is growing, but can be a tough sector for pharmaceutical companies to make money in as recent results from Novo Nordisk and Eli Lilly demonstrate. Panjiva data shows that U.S. imports of insulin and related equipment fell 15% in the third quarter in dollar ter... Read more →